The goal of our proposed multicentre prospective cohort study is to characterize perioperative usage patterns of crystalloids and albumin, as well as key patient outcomes, in cardiac surgical patients. Results obtained from this observational study will be combined with the results of other studies to clarify the optimal role of albumin and other blood products in the perioperative management of cardiac surgical patients. This study will also address numerous other knowledge gaps in the area of perioperative blood product management and fluid administration in cardiac surgery and define a collaborative group to support future research in this field.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Albumin (g/L)
Timeframe: On CPB, in the operating room but not during CPB, in the ICU, on the ward to post operative day 28
Antithrombin III (g/L)
Timeframe: On CPB, in the operating room but not during CPB, in the ICU, on the ward to post operative day 28
Crystalloid
Timeframe: On CPB, in the operating room but not during CPB, in the ICU, on the ward to post operative day 28.